Cover Image
市場調查報告書

青光眼手術設備:開發平台分析

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 345366
出版日期 內容資訊 英文 114 Pages
訂單完成後即時交付
價格
Back to Top
青光眼手術設備:開發平台分析 Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年03月11日 內容資訊: 英文 114 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的青光眼手術設備開發中產品資訊相關分析,提供您臨床實驗與產品開發的進展,彙整各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品的詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 青光眼手術設備概要

第3章 開發中的產品

  • 青光眼手術設備 - 各開發階段的開發中產品
  • 青光眼手術設備 - 各市場區隔的開發中產品
  • 青光眼手術設備 -國家 (地區) 別的開發中產品
  • 青光眼手術設備 - 法規別開發中產品
  • 青光眼手術設備 - 各認證時期 (估計) 的開發中產品
  • 青光眼手術設備 - 現在進行中的臨床實驗

第4章 青光眼手術設備 - 正在開發的開發中產品:各企業

  • 青光眼手術設備企業 - 各開發階段的開發中產品
  • 青光眼手術設備 - 各開發階段的開發中產品

第5章 青光眼手術設備企業與產品概要

  • Anteis S.A.
  • AqueSys, Inc.
  • Assenti, LLC
  • Camras Vision
  • Eye Sonix
  • Galaxy Ophthalmics Inc
  • Geuder AG
  • Glaukos Corporation
  • InnFocus LLC
  • Iowa State University
  • IPI Singapore
  • iScience Interventional, Inc.
  • iSTAR Medical
  • Ivantis, Inc.
  • Konan Medical Inc.
  • Kytogenics Pharmaceuticals, Inc.
  • Massachusetts Eye and Ear Infirmary
  • Medtronic plc
  • Meir Medical Center
  • Ocular Therapeutix, Inc.
  • Oculox Technology Sagl
  • Ocumatrx
  • OcuTherix, Inc.
  • OPKO Health, Inc.
  • OptoLight Vision Technology
  • PolyActiva Pty Ltd
  • Queen's University
  • Refocus Group, Inc.
  • SOLX, Inc.
  • Tel Aviv University
  • TonoGuard Ltd.
  • Transcend Medical, Inc.
  • University of Rostock
  • ViSci Ltd.
  • Westhouse Medical Services Plc

第6章 青光眼手術設備 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0153EPD

GlobalData's Medical Devices sector report, "Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Glaucoma Surgery Devices Overview

3. Products under Development

  • 3.1. Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • 3.2. Glaucoma Surgery Devices - Pipeline Products by Segment
  • 3.3. Glaucoma Surgery Devices - Pipeline Products by Territory
  • 3.4. Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • 3.5. Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • 3.6. Glaucoma Surgery Devices - Ongoing Clinical Trials

4. Glaucoma Surgery Devices - Pipeline Products under Development by Companies

  • 4.1. Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Glaucoma Surgery Devices - Pipeline Products by Stage of Development

5. Glaucoma Surgery Devices Companies and Product Overview

  • 5.1. Allergan Plc Company Overview
    • 5.1.1. Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Anteis S.A. Company Overview
    • 5.2.1. Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Assenti, LLC Company Overview
    • 5.3.1. Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Camras Vision Company Overview
    • 5.4.1. Camras Vision Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Ellex Medical Lasers Limited Company Overview
    • 5.5.1. Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Eye Sonix Company Overview
    • 5.6.1. Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Galaxy Ophthalmics Inc Company Overview
    • 5.7.1. Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Geuder AG Company Overview
    • 5.8.1. Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Glaukos Corporation Company Overview
    • 5.9.1. Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. InnFocus LLC Company Overview
    • 5.10.1. InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. IPI Singapore Company Overview
    • 5.11.1. IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. iSTAR Medical Company Overview
    • 5.12.1. iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Ivantis, Inc. Company Overview
    • 5.13.1. Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Konan Medical Inc. Company Overview
    • 5.14.1. Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Kytogenics Pharmaceuticals, Inc. Company Overview
    • 5.15.1. Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Massachusetts Eye and Ear Infirmary Company Overview
    • 5.16.1. Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Medtronic plc Company Overview
    • 5.17.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Meir Medical Center Company Overview
    • 5.18.1. Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. MicroOptx, Inc. Company Overview
    • 5.19.1. MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Ocular Therapeutix, Inc. Company Overview
    • 5.20.1. Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Oculox Technology Sagl Company Overview
    • 5.21.1. Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Ocumatrx Company Overview
    • 5.22.1. Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. OcuTherix, Inc. Company Overview
    • 5.23.1. OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. OPKO Health, Inc. Company Overview
    • 5.24.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. OptoLight Vision Technology Company Overview
    • 5.25.1. OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. PolyActiva Pty Ltd Company Overview
    • 5.26.1. PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Queen's University Company Overview
    • 5.27.1. Queen's University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Refocus Group, Inc. Company Overview
    • 5.28.1. Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. SOLX, Inc. Company Overview
    • 5.29.1. SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Tel Aviv University Company Overview
    • 5.30.1. Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. TonoGuard Ltd. Company Overview
    • 5.31.1. TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Transcend Medical, Inc. Company Overview
    • 5.32.1. Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. University of Rostock Company Overview
    • 5.33.1. University of Rostock Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. ViSci Ltd. Company Overview
    • 5.34.1. ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Westhouse Medical Services Plc Company Overview
    • 5.35.1. Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview

6. Glaucoma Surgery Devices- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment
  • Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory
  • Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
  • Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Table 9: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: XEN45 - Product Status
  • Table 11: XEN45 - Product Description
  • Table 12: Allergan Plc - Ongoing Clinical Trials Overview
  • Table 13: XEN45 - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects with Refractory Glaucoma
  • Table 14: XEN45 - Ab Interno Gelatin Stent with Mitomycin-C Combined with Cataract Surgery for Treatment of Open-angle Glaucoma
  • Table 15: XEN45 - Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects
  • Table 16: Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Drainage Viscoelastic Injectable Implant - Product Status
  • Table 18: Drainage Viscoelastic Injectable Implant - Product Description
  • Table 19: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Intraocular Pressure Monitoring System - Product Status
  • Table 21: Intraocular Pressure Monitoring System - Product Description
  • Table 22: Camras Vision Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Camras Shunt - Product Status
  • Table 24: Camras Shunt - Product Description
  • Table 25: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Glaucoma Device - Product Status
  • Table 27: Glaucoma Device - Product Description
  • Table 28: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Therapeutic Ultrasound Device - Glaucoma - Product Status
  • Table 30: Therapeutic Ultrasound Device - Glaucoma - Product Description
  • Table 31: Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Implantable Glaucoma Therapy Device - Product Status
  • Table 33: Implantable Glaucoma Therapy Device - Product Description
  • Table 34: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: MikroAug - Product Status
  • Table 36: MikroAug - Product Description
  • Table 37: Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: GTS400 - Product Status
  • Table 39: GTS400 - Product Description
  • Table 40: iStent Inject - Cataract Surgery - Product Status
  • Table 41: iStent Inject - Cataract Surgery - Product Description
  • Table 42: iStent Inject - Standalone Procedures - Product Status
  • Table 43: iStent Inject - Standalone Procedures - Product Description
  • Table 44: iStent Supra - Product Status
  • Table 45: iStent Supra - Product Description
  • Table 46: Glaukos Corporation - Ongoing Clinical Trials Overview
  • Table 47: iStent Supra - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin
  • Table 48: iStent Supra - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment with Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
  • Table 49: iStent Inject - Cataract Surgery - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment with One or Two Trabecular Micro-bypass Stents in Conjunction with Cataract Surgery
  • Table 50: iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery
  • Table 51: InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: InnFocus Microshunt - Product Status
  • Table 53: InnFocus Microshunt - Product Description
  • Table 54: InnFocus LLC - Ongoing Clinical Trials Overview
  • Table 55: InnFocus Microshunt - InnFocus MicroShunt FDA clinical trial
  • Table 56: InnFocus Microshunt - Post Market Study to Evaluate Safety and Effectiveness of the InnFocus Microshunt (MIDI Arrow) in Patients with Primary Open Angle Glaucoma
  • Table 57: InnFocus Microshunt - Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) to Relieve Glaucoma Symptoms
  • Table 58: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Pressure-Sensitive Glaucoma Drainage Device - Product Status
  • Table 60: Pressure-Sensitive Glaucoma Drainage Device - Product Description
  • Table 61: iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: STARflo MINI - Product Status
  • Table 63: STARflo MINI - Product Description
  • Table 64: STARflo Plus Glaucoma Implant - Product Status
  • Table 65: STARflo Plus Glaucoma Implant - Product Description
  • Table 66: Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Hydrus Microstent - Product Status
  • Table 68: Hydrus Microstent - Product Description
  • Table 69: Ivantis, Inc. - Ongoing Clinical Trials Overview
  • Table 70: Hydrus Microstent - A Prospective, Multi-center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
  • Table 71: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
  • Table 72: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent for Lowering Intraocular Pressure in Primary Open Angle Glaucoma
  • Table 73: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial
  • Table 74: Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: Bionocular Analytic Dynamic Pupillometer - Product Status
  • Table 76: Bionocular Analytic Dynamic Pupillometer - Product Description
  • Table 77: Konan Medical Inc. - Ongoing Clinical Trials Overview
  • Table 78: Bionocular Analytic Dynamic Pupillometer - The Detection of Glaucoma Using Pupillography
  • Table 79: Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: MACC-Based Device - Glaucoma Filtering - Product Status
  • Table 81: MACC-Based Device - Glaucoma Filtering - Product Description
  • Table 82: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Pressure Relief Valve Shunt - Product Status
  • Table 84: Pressure Relief Valve Shunt - Product Description
  • Table 85: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: CellPlant - Product Status
  • Table 87: CellPlant - Product Description
  • Table 88: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Glaucoma Drainage Device - Product Status
  • Table 90: Glaucoma Drainage Device - Product Description
  • Table 91: MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: BG Implant Shunt - Product Status
  • Table 93: BG Implant Shunt - Product Description
  • Table 94: Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Travoprost Punctum Plug - Product Status
  • Table 96: Travoprost Punctum Plug - Product Description
  • Table 97: Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Foldable Intraocular Pressure Sensor Device - Product Status
  • Table 99: Foldable Intraocular Pressure Sensor Device - Product Description
  • Table 100: Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: CaPRI Device - Product Status
  • Table 102: CaPRI Device - Product Description
  • Table 103: OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: Deep Wave Trabeculoplasty Device - Product Status
  • Table 105: Deep Wave Trabeculoplasty Device - Product Description
  • Table 106: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: Aquashunt - Product Status
  • Table 108: Aquashunt - Product Description
  • Table 109: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Lipshitz Macular Implant For Advanced Glaucoma - Product Status
  • Table 111: Lipshitz Macular Implant For Advanced Glaucoma - Product Description
  • Table 112: PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Fully Bioerodible Ocular Implant - Glaucoma - Product Status
  • Table 114: Fully Bioerodible Ocular Implant - Glaucoma - Product Description
  • Table 115: Queen's University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Laser Adjustable Suture - Product Status
  • Table 117: Laser Adjustable Suture - Product Description
  • Table 118: Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: PresVIEW Scleral Implant - Glaucoma - Product Status
  • Table 120: PresVIEW Scleral Implant - Glaucoma - Product Description
  • Table 121: SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: SOLX Gold Shunt - Product Status
  • Table 123: SOLX Gold Shunt - Product Description
  • Table 124: SOLX, Inc. - Ongoing Clinical Trials Overview
  • Table 125: SOLX Gold Shunt - Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
  • Table 126: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Direct Laser Trabeculoplasty System - Product Status
  • Table 128: Direct Laser Trabeculoplasty System - Product Description
  • Table 129: Glaucoma Implant - Product Status
  • Table 130: Glaucoma Implant - Product Description
  • Table 131: TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 132: EasyIOP - Product Status
  • Table 133: EasyIOP - Product Description
  • Table 134: Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: CyPass Micro-Stent - Product Status
  • Table 136: CyPass Micro-Stent - Product Description
  • Table 137: Transcend Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 138: CyPass Micro-Stent - A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-assisted CyPass Micro-Stent Implantation in Patients with Open Angle Glaucoma
  • Table 139: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview
  • Table 140: PTX-Eluting Microstent - Product Status
  • Table 141: PTX-Eluting Microstent - Product Description
  • Table 142: ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 143: Sub-Conjunctival Drug Implant - Product Status
  • Table 144: Sub-Conjunctival Drug Implant - Product Description
  • Table 145: Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 146: Pneumatic Trabeculoplasty System - Product Status
  • Table 147: Pneumatic Trabeculoplasty System - Product Description
  • Table 148: Glossary

List of Figures

  • Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
  • Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment
  • Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory
  • Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
  • Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Back to Top